Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  6. 8-K Event Other events
  7. 8-K Event Shareholder vote results
  8. DEFA14A Proxy Proxy Materials
  9. 8-K Event Executive or director change
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. ARS Other Annual Report to Security Holders
  14. DEF 14A Proxy Proxy Statement
  15. 8-K Event Exit or restructuring costs · Executive or director change · Other events
  16. PRE 14A Proxy Proxy Statement (Preliminary)
  17. 8-K Event Other events
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 424B5 Offering Prospectus
  20. 10-K Report Annual Report

Page 18 of 42 · 823 filings